The value of a European registry for pituitary adenomas: The example of Cushing's syndrome registry

Keyphrases

• Care Planning 33%
• Clinical Practice 33%
• Clinical Research 66%
• Clinical Support 33%
• Clinical Trials 33%
• Cushing's Syndrome 100%
• Disease Registry 33%
• Endocrinologist 33%
• Europe 66%
• European Medicines Agency 33%
• European Registries 100%
• Improvement Research 33%
• Marketing Authorization 66%
• New Drugs 33%
• Orphan Drugs 66%
• Patient Care 33%
• Patient Care Planning 33%
• Patient Database 33%
• Patient Health Care 33%
• Pituitary Adenoma 100%
• Post-marketing Surveillance 33%
• Practice Conditions 33%
• Rare Disease Registry 66%
• Regulated Industries 33%
• Required Sample Size 33%
• Somatostatin Analogs 33%
• Treatment Efficacy 33%

Medicine and Dentistry

• Clinical Research 66%
• Clinical Trial 33%
• Cushing Syndrome 100%
• Diseases 33%
• Endocrinologist 33%
• Orphan Drug 66%
• Patient Care 33%
• Patient Registry 33%
• Pituitary Adenoma 100%
• Rare Disease 66%
• Side Effect 33%
• Somatostatin Derivative 33%